New Therapy Targeting microRNA-214 Blocks Ulcerative Colitis Disease Progression

New Therapy Targeting microRNA-214 Blocks Ulcerative Colitis Disease Progression
Scientists at the UCLA Jonsson Comprehensive Cancer Center developed a new therapy that blocks progression of ulcerative colitis and colon cancer in mice. Together with Crohn’s disease, ulcerative colitis is the most common type of Inflammatory Bowel Disease (IBD), a disease characterized by inflammation in the digestive tract — including the mouth, esophagus, stomach, small

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *